These patients tended to have a higher frequency of histologic types other than adenocarcinoma (squamous cell carcinoma, non-small cell lung cancer-not otherwise specified: NSCLC-NOS), a higher frequency of EGFR gene mutations (44.4%), and a higher frequency of therapeutic induction with ICI (22.2%). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.